An ADHD diagnosis can be expensive and inaccurate. This company’s test addresses both problems

 ADHD in the News 2022-08-11


As companies like Cerebral and Done come under fire for their ADHD prescribing practices, a Swedish company’s telehealth-friendly diagnostic test could offer a more objective, and accurate, alternative.

View Article: Fast Company, August 7, 2022




Other Articles in this Edition

An ADHD diagnosis can be expensive and inaccurate. This company’s test addresses both problems

More Evaluations Needed for Transcranial Direct Current Stimulation Efficacy in Neurodevelopmental Disorders

Medication Doesn’t Help Kids With ADHD Learn

School Leaders With Disabilities: ‘It’s Important to Share That You’re Not Alone’: How personal experience informs their work with vulnerable students

Health expert joins studio to discuss possible breakthrough in ADHD treatment

High school athletes in contact sports more likely to misuse prescription stimulants throughout their 20s

How can you support kids with ADHD to learn? Parents said these 3 things help

When Passive Aggression Could Be Something Worse: Difficult behavior may dovetail with other issues or more serious disorders.